2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
Jacqueline Cloos(Vrije Universiteit Amsterdam), Michael Heuser(Martin Luther University Halle-Wittenberg), Francesco Buccisano(University of Rome Tor Vergata), Andrew H. Wei(The Royal Melbourne Hospital), Christian Thiede(University Hospital Carl Gustav Carus), Gail J. Roboz(Cornell University), Arjan A. van de Loosdrecht(Dutch Cancer Society), Roland B. Walter(Rafael Advanced Defense Systems (Israel)), Brent L. Wood(University of Southern California), Adriana Pleșa(Hospices Civils de Lyon), Agnieszka Wierzbowska(Medical University of Lodz), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Anna Czyż(Wroclaw Medical University), Ing Soo Tiong(The University of Melbourne), Sylvie Freeman(University of Birmingham), Luca Maurillo(University of Rome Tor Vergata), Yishai Ofran(Shaare Zedek Medical Center), Veit Bücklein(LMU Klinikum), Christophe Roumier(Université de Lille), Constance Baer(Munich Leukemia Laboratory (Germany)), Costa Bachas(Amsterdam University Medical Centers), Maura Rosane Valério Ikoma(Hospital Amaral Carvalho), François Vergez(Centre National de la Recherche Scientifique), Jad Othman(The University of Sydney), Wolfgang Kern(Munich Leukemia Laboratory (Germany)), Bert A. van der Reijden(Radboud University Nijmegen), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Konstanze Döhner(University Hospital Ulm), David C. de Leeuw(Dutch Cancer Society), Felicitas Thol(Medizinische Hochschule Hannover), Christopher S. Hourigan(National Heart Lung and Blood Institute), Peter J.M. Valk(Erasmus MC Cancer Institute), Agata Majchrzak(Copernicus Memorial Hospital), Michaela Feuring(University Hospital Ulm), Aguirre Mimoun(Université de Bordeaux), Barbara Depreter(Vrije Universiteit Brussel), Sa A. Wang(Beijing Institute of Technology), Tom Reuvekamp(Amsterdam Neuroscience), Gert J. Ossenkoppele(Dutch Cancer Society), Adriano Venditti(University of Rome Tor Vergata), Richard Dillon(King's College London), Lukas H. Haaksma(Dutch Cancer Society), Farhad Ravandi(The University of Texas MD Anderson Cancer Center)
Cited by 22
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k